NTFP-106
Pre-clinical- Indications
- Erectile dysfunction
Company intelligence / Profile preview
NOVA Thin Film Pharmaceuticals develops and manufactures dissolving thin films using its proprietary DepoFilm™ technology. This platform aims to provide more efficient, patient-friendly drug delivery with improved formulation flexibility and lower manufacturing costs compared to conventional wet-cast films. The company has filed multiple patents related to dosage forms and pharmacokinetics. It operates R&D in Greensboro, NC, with manufacturing at Quality Chemical Laboratories in Wilmington.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NOVA Thin Film Pharmaceuticals.